Vaxxinity, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €1.41M
    Gross profit
    -€1.41M
    SG&A expenses
    €19.33M
    R&D expenses
    €30.54M
    EBITDA
    -€47.32M
    D&A
    €1.91M
    EBIT
    -€50.25M
    Interest expenses
    €599.64K
    EBT
    -€49.05M
    Tax expenses
    €0.00
    Net income
    -€49.05M

    Cash flow statement

    Net deferred tax
    -€1.05M
    Non-cash items
    €688.31K
    Changes in working capital
    -€7.36M
    Operating cash flow
    -€49.31M
    Capex
    €691.82K
    Other investing cash flow
    -€5.27M
    Net investing cash flow
    €24.85M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €387.70K
    Debt repayment
    -€1.37M
    Other financing cash flow
    €391.14K
    Net financing cash flow
    -€982.17K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€25.44M
    Cash at end of period
    €4.34M
    Free cash flow
    -€48.62M

    Balance sheet

    Cash and cash equivalents
    €4.25M
    Cash and short-term investments
    €26.19M
    Total receivables
    €356.68K
    Inventory
    €0.00
    Other current assets
    €814.16K
    Total current assets
    €28.63M
    Property, plant & equipment
    €9.55M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €9.55M
    Total assets
    €38.18M
    Accounts payable
    €1.54M
    Short-term debt
    €1.64M
    Other current liabilities
    €11.99M
    Total current liabilities
    €15.17M
    Long-term debt
    €11.43M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €30.15K
    Total non-current liabilities
    €11.46M
    Total liabilities
    €26.62M
    Common stock
    €239.51K
    Retained earnings
    -€311.57M
    Other equity
    €6.89K
    Total equity
    €11.55M
    Total liabilities and shareholders' equity
    €38.18M

    Company information

    Market capitalization
    €1.95B
    Employees
    57
    Enterprise Value
    €11.50M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -424.6% Much better than peer group: -3,798.6%
    ROA
    -128.5% Much better than peer group: -7,056.6%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -2.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€860.57K

    Notifications